Search alternatives:
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant body (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
Showing 141 - 160 results of 5,659 for search '(( significant spatial decrease ) OR ( significant fold decrease ))', query time: 0.24s Refine Results
  1. 141
    IFNγ+LPS up-regulated DEGs identified by RRA and fold-change analysis.

    IFNγ+LPS up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

    Published 2024
    Save to List
    Saved in:
  2. 142
    <i>Ang1</i>-deficient mice develop significantly fewer tumors compared to WT mice following AOM-DSS.

    <i>Ang1</i>-deficient mice develop significantly fewer tumors compared to WT mice following AOM-DSS. by Alexander Hu (14755811)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 143
    IR-induced mutation profiles of DNA repair mutants significantly different from wild-type.

    IR-induced mutation profiles of DNA repair mutants significantly different from wild-type. by Bettina Meier (274833)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 144
    Relations between Lnc THRIL and MiR-125b and clinical data in UC patients.

    Relations between Lnc THRIL and MiR-125b and clinical data in UC patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 145
    Correlations of Lnc THRIL and MiR 125b with study parameters among UC patients.

    Correlations of Lnc THRIL and MiR 125b with study parameters among UC patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 146
    Demographic, biochemical and clinical characteristics of the study groups.

    Demographic, biochemical and clinical characteristics of the study groups. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 147
    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls.

    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 148
    Relations between Lnc THRIL and MiR-125b and clinical data in CD patients.

    Relations between Lnc THRIL and MiR-125b and clinical data in CD patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 149
    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC patients vs. controls.

    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC patients vs. controls. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 150
    Correlations of Lnc THRIL and MiR 125b with study parameters among CD patients.

    Correlations of Lnc THRIL and MiR 125b with study parameters among CD patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 151
    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC vs. CD patients.

    Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC vs. CD patients. by Azza Elamir (13924199)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 152
    Analysis of sphingosine levels from BAL.

    Analysis of sphingosine levels from BAL. by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 153
    Histological studies of lungs stained with Cy3-coupled anti-ceramide antibodies.

    Histological studies of lungs stained with Cy3-coupled anti-ceramide antibodies. by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 154
    Analysis of perfusate measurements during EVLP run.

    Analysis of perfusate measurements during EVLP run. by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 155
    Analysis of functional lung parameters during EVLP run.

    Analysis of functional lung parameters during EVLP run. by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 156
    Analysis of CFU of streak cultures from BAL fluid (100 μL/plate).

    Analysis of CFU of streak cultures from BAL fluid (100 μL/plate). by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 157
    Fig 7 -

    Fig 7 - by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 158
    Mass spectrometry analysis of total sphingosine, ceramide and sphingomyelin in biopsies and tissue samples from EVLP pig lungs after infection and inhalation of sphingosine (500 μM SPH) or saline (NaCl 0.9%).

    Mass spectrometry analysis of total sphingosine, ceramide and sphingomyelin in biopsies and tissue samples from EVLP pig lungs after infection and inhalation of sphingosine (500 μM... by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 159
    Fig 1 -

    Fig 1 - by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 160
    Analysis of wet/dry ratio and total weight gain during a 3 h EVLP run.

    Analysis of wet/dry ratio and total weight gain during a 3 h EVLP run. by Henning Carstens (13132801)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: